| Literature DB >> 31810790 |
Enrico Lugli1, Giovanni Galletti2, Shannon K Boi3, Benjamin A Youngblood4.
Abstract
CD8+ T cell immunological memory of past antigen exposure can confer long-lived protection against infections or tumors. The fact that CD8+ memory T cells can have features of both naïve and effector cells has forced the field to struggle with several conceptual questions about the developmental origin of the cell and, consequently, the mechanism(s) that contribute to memory development. Here, we discuss recent conceptual advances in our understanding of memory T cell development that incorporate data describing a hybrid stem and/or effector state of differentiation. We theorize that the mechanisms involved in developing these cells could be mediated, in part, through epigenetic programs. Finally, we consider the potential therapeutic implications of inducing and/or utilizing such hybrid cells clinically.Entities:
Keywords: CD8+ T cells; TCF1; cancer immunotherapy; effector; exhaustion; memory; naïve
Mesh:
Substances:
Year: 2019 PMID: 31810790 PMCID: PMC6934921 DOI: 10.1016/j.it.2019.11.004
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 16.687